Axogen (AXGN) vs CONMED (CNMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Axogen (AXGN) has outperformed CONMED (CNMD) over the past year, gaining 110.8% versus a loss of 3.0%. Over five years, AXGN leads with a +165.6% price change compared with -68.2% for CNMD. Axogen is the larger company by market cap ($2.12 billion vs $1.35 billion), about 1.6 times the size.
On valuation, CONMED trades at a lower forward P/E (9.4x vs 52.6x for Axogen). CONMED pays a dividend yielding 0.44%, while Axogen does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AXGN | CNMD |
|---|---|---|
| Share price | $36.18 | $45.11 |
| Market cap | $2.12B | $1.35B |
| 1-day change | +0.39% | +1.99% |
| YTD return | +10.54% | +11.11% |
| 1-year return | +110.84% | -3.03% |
| 5-year return | +165.64% | -68.24% |
| P/E ratio (TTM) | — | 24.38 |
| Forward P/E | 52.59 | 9.43 |
| EPS (TTM) | $-0.67 | $1.85 |
| Dividend yield | 0.00% | 0.44% |
| Annual dividend | $0.00 | $0.20 |
| Revenue (latest FY) | $225.21M | — |
| Revenue growth (YoY) | +20.21% | — |
| Net income (latest FY) | $-15.70M | — |
| Gross margin | 74.31% | — |
| Operating margin | -3.49% | — |
| Net margin | -6.97% | — |
| 52-week high | $52.91 | $53.66 |
| 52-week low | $15.27 | $31.44 |
| Distance from 52-week high | -31.62% | -15.93% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +48.76% | +0.86% |
| Average volume | 1.22M | 493.66K |
| Shares outstanding | 58.67M | 29.95M |
| Employees | 622 | 3,900 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AXGN has outperformed CNMD by 113.9 percentage points over the past year.
About Axogen
AXGN stock →Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 622 employees
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
AXGN vs CNMD FAQ
Which is bigger, Axogen or CONMED?
Axogen (AXGN) is larger, with a market capitalization of $2.12B compared with $1.35B for CONMED (CNMD).
Which stock has performed better over the past year, AXGN or CNMD?
AXGN returned +110.84% over the past 12 months, compared with -3.03% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Axogen or CONMED?
CONMED pays a dividend yielding 0.44%, while Axogen does not currently pay a regular dividend.
Are Axogen and CONMED in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.